SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-046841
Filing Date
2023-06-06
Accepted
2023-06-06 16:40:55
Documents
13
Period of Report
2023-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea179858-8k_bluewater.htm   iXBRL 8-K 37101
2 THIRD AMENDED AND RESTATED BYLAWS OF BLUE WATER BIOTECH, INC ea179858ex3-1_bluewater.htm EX-3.1 72177
  Complete submission text file 0001213900-23-046841.txt   309364

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bwv-20230531.xsd EX-101.SCH 2983
4 XBRL LABEL FILE bwv-20230531_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bwv-20230531_pre.xml EX-101.PRE 22376
7 EXTRACTED XBRL INSTANCE DOCUMENT ea179858-8k_bluewater_htm.xml XML 3826
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 23996645
SIC: 2834 Pharmaceutical Preparations